U.S. Building Stock News

Earnings beat, guidance shock and what changed for MongoDB (MDB) MongoDB (MDB) topped expectations with its latest quarterly earnings and revenue, yet cautious guidance for the next quarter and fiscal year, leadership changes and insider selling all combined to hit the stock hard. See our latest analysis for MongoDB. At a share price of $325.01, MongoDB has seen a 6.43% 7 day share price gain but a 12.47% 30 day and 18.68% year to date share price decline. Its 1 year total shareholder return...

Exzeo Group has entered into a new partnership with Tokio Marine Highland to distribute TMH2O residential flood insurance. The collaboration expands Exzeo’s property insurance offerings and supports its ambitions as a multi-line, technology driven platform. For investors tracking NYSE:XZO, this announcement comes as the stock trades at $16.1, with a 3.7% gain over the past week and a 20.8% decline over the past month. Year to date, shares show a 29.3% decline, so this move may stand out as...

If you are wondering whether First Solar's current share price reflects its true worth, this article will walk through how that value stacks up against a range of valuation checks. The stock last closed at US$199.86, with a 17.5% decline over the past 7 days and an 11.4% decline over the past 30 days, although the 1 year return sits at 56.6% and the 5 year return at 179.7%. These moves come as First Solar continues to sit in the spotlight of the wider solar and semiconductor industry, with...

Paramount Skydance agreed to acquire Warner Bros. Discovery (NasdaqGS:WBD) in an all stock and cash transaction valued at about $110b. The deal, which follows a bidding contest in which Netflix dropped out, is expected to close in Q3 2026, subject to regulatory and shareholder approval. The combined group plans to bring together HBO Max and Paramount+, along with major film and TV franchises under one media company. Warner Bros. Discovery enters this deal with its shares at $28.5 and a 1...

Ethereum rally puts Sharplink’s treasury model in focus Sharplink (SBET) is back on watch after Ethereum’s latest rally, with the company’s large ETH treasury and staking driven business model pulling the stock closely in line with crypto market moves. See our latest analysis for Sharplink. At a share price of US$7.39, Sharplink’s stock has recently swung higher with a 1-day share price return of 8.36% and a 7-day share price return of 13.87%. These short bursts follow a weaker patch marked...

Vistra overview and recent share performance Vistra (VST) has recently drawn attention after a period of mixed share performance, with the stock showing a small monthly gain alongside a modest decline over the past 3 months and the past week. For context, the company last closed at $165.99, with a year-to-date return close to flat and a 1-year total return above 30%. Over longer periods, total returns over 3 and 5 years have been very large, reflecting a multi-year move that existing...

Event overview and recent share performance Charles River Laboratories International (CRL) has drawn investor attention after recent share price moves, with the stock flat over the past day, up about 9% over the past week, but showing a 15% decline over the past month. Over the past 3 months, Charles River has posted a small positive total return, while year to date the stock is down about 12%. Over the past year, it has delivered roughly 9% total return, set against weaker 3 year and 5 year...

The Morning Bull - US Market Morning Update Tuesday, Mar, 3 2026 US stock futures are pointing lower this morning, with E mini S&P 500 contracts down about 1.5%, the Nasdaq 100 futures off nearly 2% and small cap Russell 2000 futures lower by about 2.6%. The pressure comes as the US 10 year Treasury yield holds near 4.04%, which keeps borrowing costs elevated for households and businesses, and as global government bond yields in the UK and Europe climb on renewed inflation worries tied to...

Haemonetics (HAE) is back in focus after receiving FDA 510(k) clearance for its NexSys PCS Plasma Collection System with Persona PLUS, a next-generation platform designed to tailor plasma collection volumes to individual donors. See our latest analysis for Haemonetics. Despite the FDA clearance and recent conference appearance, Haemonetics’ share price, last closing at $63.88, shows mixed momentum. The stock has a 4.23% 7 day share price return, but a 20.13% decline year to date and a 20.93%...

If you are wondering whether Matador Resources at around US$54.12 is priced attractively or already baking in a lot of optimism, you are not alone. The stock has returned 5.8% over the last 7 days, 19.6% over the last 30 days, 24.8% year to date, 16.9% over 1 year, 0.7% over 3 years and 131.2% over 5 years, which naturally raises questions about what is already reflected in the price. Recent attention on Matador Resources has focused on its position in the US energy sector and how investors...

Former Goldman Sachs (NYSE:GS) CEO Lloyd Blankfein has warned of potential systemic risks tied to the rapid expansion of private credit and shadow banking. His comments focus on hidden leverage and illiquid assets that may sit outside traditional bank balance sheets. The warning comes as investors pay closer attention to how credit risk is distributed across banks, non bank lenders, and the broader financial system. Goldman Sachs is a global investment bank and financial services firm...

Why Everpure’s latest earnings matter for shareholders Everpure (PSTG) has drawn fresh attention after reporting fourth quarter and full year results alongside new revenue guidance and an update on its share repurchase activity, giving investors several moving pieces to assess. For the fourth quarter ended February 1, 2026, the company reported revenue of US$1,058.9 million, compared with US$879.84 million a year earlier. Net income for the period was US$100.25 million versus US$42.44 million...

If you are wondering whether Alaska Air Group is attractively priced at its current level, looking closely at how its valuation stacks up against its fundamentals can help frame that decision. The stock last closed at US$50.77, with returns of 0.3% over the past 7 days, a 0.1% decline over 30 days, a 1.5% decline year to date, a 27.4% decline over 1 year, a 6.0% gain over 3 years and a 25.3% decline over 5 years, which gives you a mixed picture of recent and longer term performance. Recent...

Event-driven snapshot of Novo Nordisk (NYSE:NVO) Novo Nordisk (NYSE:NVO) has drawn investor attention after its recent share performance, with the stock showing a 0.8% move over the past day and declines over the past week, month, and past 3 months. See our latest analysis for Novo Nordisk. That 0.8% 1 day share price gain comes after a sharp 36.5% 30 day share price decline and a 27.9% year to date share price fall, while the 1 year total shareholder return of 56.9% and 3 year total...

Sable Offshore (SOC) is back on investor radar after FourWorld Capital Management took a large new stake, just as the company reported a US$410.2 million full year 2025 net loss tied to restart related costs. See our latest analysis for Sable Offshore. The share price has been volatile, with a 90 day share price return of 90.69% from a low base. However, the 1 year total shareholder return of 67.06% and year to date share price return of 26.68% indicate that longer term momentum has faded. If...

Why Remitly’s leadership shift and profit milestone matter for shareholders Remitly Global (RELY) has drawn fresh attention after appointing Sebastian J. Gunningham as CEO, while co founder Matt Oppenheimer becomes Chairman, alongside earnings that show a return to profitability and new guidance for 2026. See our latest analysis for Remitly Global. The recent CEO transition and profit update come as Remitly’s share price, now at $16.93, has logged a 30 day share price return of 28.06% and a...

Medtronic (NYSE:MDT) has launched its MiniMed Go Smart MDI system with the integrated Simplera sensor across Europe. The system connects smart insulin pen and sensor data into a single mobile app aimed at people using multiple daily injections for diabetes management. This marks a fresh product rollout for Medtronic's diabetes portfolio that has not featured in recent company news coverage. For investors watching Medtronic at a share price of $98.1, this launch adds a new element to the...

If you are wondering whether AutoZone's share price still reflects good value after a long run in the auto parts sector, this article will help you break that question into clear valuation checks. AutoZone shares most recently closed at US$3,882.47, with returns of 1.4% over 7 days, 4.8% over 30 days, 17.5% year to date, 11.6% over 1 year, 54.1% over 3 years and 212.8% over 5 years. This gives plenty of history for investors to consider. Recent news coverage around AutoZone has focused on...

Why Arhaus Stock Is Drawing Attention Now Arhaus (ARHS) has pulled back recently, with the share price down over the past month and past 3 months. This move is prompting investors to reassess how its current valuation lines up with the underlying business. The company reports annual revenue of US$1,379.2m and net income of US$67.3m, and some models suggest the shares trade at a sizeable discount to certain intrinsic value estimates. This can attract interest from value oriented investors. See...

NANO Nuclear Energy Inc. recently signed a Memorandum of Understanding with Abu Dhabi–based EHC Investment L.L.C. to explore a joint venture for deploying its KRONOS MMR™ Energy System and associated supply chains in the UAE and potentially across the wider Gulf region. The agreement underscores growing interest in micro modular reactors as a carbon free power option for energy intensive infrastructure such as data centers and industrial facilities, while NANO Nuclear and EHC assess...

Simon Property Group (SPG) has drawn fresh attention after its recent share performance, with the stock closing at $203.16 and posting gains over the past week, month, past 3 months and year. See our latest analysis for Simon Property Group. While the share price slipped 0.34% on the day to US$203.16, the 30 day share price return of 6.19% and year to date gain of 10.43% suggest momentum has been building, supported by a 1 year total shareholder return of 13.68% and very strong 3 and 5 year...

The Justice Department’s trial seeking to break up Live Nation Entertainment (LYV) and Ticketmaster puts antitrust risk at the center of the story, as investors weigh potential changes to the company’s structure and ticketing power. See our latest analysis for Live Nation Entertainment. The share price, now at US$161.81, has had an 11.25% 30 day share price return and a 25.88% 90 day share price return. The 3 year total shareholder return of 122.88% sets the backdrop for how investors are...

In late February 2026, Bloom Energy reported fourth-quarter 2025 results that exceeded analyst expectations, with earnings per share of US$0.45 and revenue about 21.5% above forecasts, alongside strong backlog growth from data center and commercial customers. This performance, set against growing interest in solid oxide electrolyzer technology and policy support for low-carbon hydrogen, highlighted how Bloom’s positioning at the intersection of hydrogen and on-site power is becoming...

If you are wondering whether Hartford Insurance Group shares still offer value after a strong run, it helps to step back and look at what the current price is really implying. The stock last closed at US$141.86, with returns of 0.9% over 7 days, 5.0% over 30 days, 3.5% year to date, 20.4% over 1 year, 93.2% over 3 years and 186.4% over 5 years. This naturally raises questions about how much of the story is already priced in. Recent news around Hartford has focused on its position within the...